Status:
WITHDRAWN
Impact of Omalizumab on Corticosteroid Use, Emergency Room Visits and Hospitalizations
Lead Sponsor:
Novartis Pharmaceuticals
Conditions:
Asthma
Eligibility:
All Genders
12+ years
Brief Summary
A retrospective database analysis to evaluate the impact of omalizumab on the use of corticosteroid, emergency-department visits and hospitalizations among patients with uncontrolled asthma and using ...
Eligibility Criteria
Inclusion
- ≥12 years of age with a documented Cystic fibrosis (CF) diagnosis,
- on Long acting Beta antagonist- Inhaled Corticosteroid (LABA-ICS) at baseline,
- uncontrolled asthma at baseline.
Exclusion
- Other protocol-defined inclusion/exclusion criteria may apply.
Key Trial Info
Start Date :
May 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01460862
Start Date
May 1 2011
End Date
May 1 2011
Last Update
December 7 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.